AC Immune SA Annual Research And Development Expense in CHF from 2015 to 2023

Taxonomy & unit
ifrs-full: CHF
Summary
AC Immune SA quarterly/annual Research And Development Expense history and growth rate from 2015 to 2023.
  • AC Immune SA Research And Development Expense for the quarter ending June 30, 2024 was ₣17.1M, a 25.3% increase year-over-year.
  • AC Immune SA annual Research And Development Expense for 2023 was ₣54.6M, a 9.5% decline from 2022.
  • AC Immune SA annual Research And Development Expense for 2022 was ₣60.3M, a 3.12% decline from 2021.
  • AC Immune SA annual Research And Development Expense for 2021 was ₣62.3M, a 4.7% increase from 2020.
Research And Development Expense, Trailing 12 Months (CHF)
Research And Development Expense, Annual (CHF)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 54.6M -5.73M -9.5% Jan 1, 2023 Dec 31, 2023 20-F 2024-03-14
2022 60.3M -1.95M -3.12% Jan 1, 2022 Dec 31, 2022 20-F 2024-03-14
2021 62.3M +2.8M +4.7% Jan 1, 2021 Dec 31, 2021 20-F 2024-03-14
2020 59.5M +9.06M +18% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-16
2019 50.4M +6.16M +13.9% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-22
2018 44.3M +11.6M +35.6% Jan 1, 2018 Dec 31, 2018 20-F 2021-03-23
2017 32.7M +6.89M +26.7% Jan 1, 2017 Dec 31, 2017 20-F 2020-03-30
2016 25.8M +8.73M +51.2% Jan 1, 2016 Dec 31, 2016 20-F 2019-03-21
2015 17M Jan 1, 2015 Dec 31, 2015 20-F 2018-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.